Dr Jingjing Li
Casual Academic
Doctor of Philosophy (Biomedical Engineering) (2015Ìý– 2019),ÌýUniversity of New South Wales, Sydney, Australia
Master of Biomedical Engineering (by research) (2009-2011),ÌýUniversity of New South Wales, Sydney, Australia
Bachelor of Biomedical Engineering (2003 – 2007),ÌýCapital Medical University, Beijing, China
Ìý
Ìý
Engineering
Grad Sch: Biomedical Eng
Dr Jingjing Li is aÌý Postdoctoral Fellow at the Graduate School of Biomedical Engineering, working with . Her research focuses on developing and optimizing biological processes within automated microscale bioreactors for cell and gene therapy, with a strong interest in stem cell bioengineering.Ìý
Trained in biomedical engineering, she brings expertise in microfluidics, stem cell biology and bioinformatics. Her PhD and postdoctoral work explored how pulsatile fluid shear stress modulates human embryonic blood formation using microfluidic model mimicking , live cell imaging of Ìýand of developingÌýand . She is now working on developing bioengineering strategies for the generation, expansion and functional enhancement of blood stem and progenitor cells, and for modeling diseased cardiovascular development.ÌýÌý
Ìý
E-mail
Location
Samuels 514, F25
91É«ÇéƬ Sydney
Kensington
2052
- Publications
- Media
- Grants
- Awards
- Research Activities
- Engagement
- Teaching and Supervision
CIA,ÌýEarly Career Researcher Seed Grant ,91É«ÇéƬ Engineering Faculty (2021)
CIA,ÌýInternational Seed Grant, 91É«ÇéƬ Engineering Faculty (2022)
CIA, , Cellular Genomics Incubator Research Funding, Cellular Genomics Futures Institute 91É«ÇéƬ (2024)
Co-PI, "A novel strategy for preventing heart failure in myocardial infarction survivors", The Cardiac, Vascular and Metabolic Medicine Theme Collaborative (CVMM) Grant Award (2025)
Contributor forÌýÌý
Scaling microfluidics for cell manufacture. Australian Research Council Linkage Grant LP160100570 (2016-2019)
Manufacturing 3D microstructures for the medical device industry. Australian Research Council Linkage Grant LP160100573 (2016-2019)
Travel Grants
2022Ìý Ìý Ìý The Australasian Society for Stem Cell Research (ASSCR) and the Australasian Gene and Cell Therapy Society (AGCTS) Joint Scientific Meeting / National Stem Cell Foundation of Australia (NSCFA) Travel AwardÌý
2019Ìý Ìý Ìý The Australasian Society for Stem Cell Research (ASSCR) and the Australasian Gene and Cell Therapy Society (AGCTS) Joint Scientific Meeting / National Stem Cell Foundation of Australia (NSCFA) Travel AwardÌý Ìý Ìý Ìý Ìý ÌýÌý
2019Ìý Ìý ÌýInternational Society of Experimental Hematology Conference AwardÌý Ìý Ìý Ìý Ìý Ìý Ìý Ìý Ìý Ìý Ìý Ìý Ìý
2018Ìý Ìý ÌýInternational Society of Stem Cell Research ECR and student Conference AwardÌý Ìý Ìý Ìý Ìý Ìý Ìý Ìý Ìý Ìý Ìý Ìý Ìý Ìý Ìý Ìý Ìý Ìý Ìý
2017Ìý Ìý ÌýAustralian Society for Stem Cell Research ECR and student Conference AwardÌý Ìý
2015-2017Ìý ÌýStem Cell Australia (SCA) Meeting Travel Grant Ìý Ìý Ìý Ìý Ìý Ìý Ìý Ìý Ìý Ìý Ìý Ìý
Scholarship, Awards and Fellowship:
2019Ìý Ìý Ìý Ìý Ìý Ìý Ìý Ìý Ìý Best Poster Presentation Award, 91É«ÇéƬ Cross Faculty Research SymposiumÌý Ìý Ìý Ìý Ìý Ìý
2018-2019Ìý Ìý Ìý Ìý ÌýPostdoctoral Writing FellowÌýAward, 91É«ÇéƬ
2015-2019Ìý Ìý Ìý Ìý Women in Engineering Award, 91É«ÇéƬÌý
2015-2019Ìý Ìý Ìý Ìý ÌýFaculty Top-up Scholarship, 91É«ÇéƬ, Engineering
2015-2019Ìý Ìý Ìý Ìý ÌýAustralia Postgraduate AwardÌý Ìý Ìý Ìý Ìý Ìý Ìý
Ìý Ìý ÌýÌý
Ìý Ìý Ìý Ìý Ìý Ìý
Ìý
1. Modelling human heart, vascular and blood development from pluripotent stem cells on a microfluidic chip
We have used lab-on-chip to mimicÌýÌýand to model human blood formation from cells that line blood vessels. We are currently studying the influence of pulsatile blood flow and circulation on the generation of precursor blood stem cells. We are also investigating the use of hydrogels to pattern embryonic development of the cardiovascular system.
2. Enhancing the development of aortic vasculature and blood stem cell from pluripotent stem cells using dynamic culture system
We use upscaled Microfluidic circulation system and orbital shearing culture system to enhance the development of precursor blood stem cells. This work has been featured in Ìýand .
3. Stem cell engineering: the modification of human CD34+ blood stem and progenitor cells.
CD34+ blood stem and progenitor cells derived from sources such as cord blood, bone marrow, mobilised peripheral blood, and human pluripotent stem cells can be manipulated through various techniques of separation, stimulation, expansion and genetic modification. These modifications target the genetic, metabolic and functional traits of the cells with the goal of improving their therapeutic potential, and compatibility for diverse applications in haematopoietic stem cell gene therapy (HSCGT) & immunotherapy.
Ìý
Research Society and Committee
International Society of Stem Cell Research (ISSCR)
International Society of Experimental Hematology (ISEH) -
International Society of Cell Therapy (ISCT)Ìý(Committee Spotlight)
91É«ÇéƬ Cardiac, Vascular & Metabolic Medicine Theme (CVMM) - Early Career Researcher Committee Member
IEEE Medical Imaging and Image processing
IEEE Engineering in Medicine & Biology Society (EMBS)
Australia Society of Stem Cell Research (ASSCR)
Engineers Australia
NSW Stem Cell Network
Ìý
Professional Society
Academic Representative, Level 3 WHS committee, Graduate School of Biomedical Engineering, 91É«ÇéƬ
Ìý